Thomas K Equels

CIK 1450324 · CEO & President · last filed 2026-03-16

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$25.9K

Companies

2

Total Filings

106

Lifetime Open-Market Net

$1.08M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AIM CEO & President 63,922 $0.41 $25.9K $401.1K 51 2026-03-16
AIM ImmunoTech Inc. (HEB) Delisted Exec. Vice Chairman/CEO/Pres. 63,041 $678.2K 55 2019-06-27

Recent Filings · Page 11 of 11

106 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2011-06-27 AIM ImmunoTech Inc. (HEB) Delisted Other (J) $0 EDGAR
2010-07-01 AIM ImmunoTech Inc. (HEB) Delisted Buy (P) $0 EDGAR
2009-09-30 AIM ImmunoTech Inc. (HEB) Delisted Grant (A) +19,455 $41.1K EDGAR
2009-06-26 AIM ImmunoTech Inc. (HEB) Delisted Grant (A) +99,483 $49.7K EDGAR
2009-06-12 AIM ImmunoTech Inc. (HEB) Delisted Grant (A) +68,182 $37.5K EDGAR
2009-03-18 AIM ImmunoTech Inc. (HEB) Delisted Grant (A) +508,528 $201.8K EDGAR
Showing 101106 of 106
Page 11 of 11
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.